follow us in feedly
MicroSmallCap

Join Our Community

Facebook

Twitter

RSS

      • Featured
      • Penny Stocks
        • Penny Stocks to Buy
        • Penny Stocks to Sell
        • Robinhood Penny Stocks
      • Robinhood Stocks
        • Top 100
        • Penny Stocks
      • Market Movers
        • Analyst Coverage
        • Earnings Reports
        • Low Float Stocks
        • PDUFA Stage
        • Short Squeeze Stocks
        • Stock Price Target Changes
        • Stocks to Buy
        • Stocks to Sell
      • Sectors
        • Cannabis
        • Consumer
        • Energy
        • Financial
        • Health
        • Mining
        • Tech
      • NewsHub
      Homezz - QuoteMedia Topics And SectorsHealth Services

      Health Services

      Editorspicks

      Else Nutrition Announces $10 Million Bought Deal and Concurrent up to $5 million Private Placement

      Sep 17 Else Nutrition Holdings Inc.
      /THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES./ VANCOUVER, BC, Sept. 15, 2020 /CNW/ – Else Nutrition Holdings Inc. (TSXV:BABY)(OTCQX:BABYF)(FSE:0YL) (“Else” or ... [Read]
      Editorspicks

      Rockwell Medical, Inc. Appoints Pharmaceutical Industry Leader Robert S. Radie to Board of Directors

      Apr 1 microsmallcap
      WIXOM, Mich., March 31, 2020 (GLOBE NEWSWIRE) — Rockwell Medical, Inc. (NASDAQ:RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming anemia management and improving outcomes for patients around the world, announced today ... [Read]
      Else Nutrition
      Editorspicks

      Else Unveils Favorable Results from a Broad U.S. Consumer Research Study, Including Strong Purchase Intent

      Jan 27 Else Nutrition Holdings Inc.
      VANCOUVER, BRITISH COLUMBIA / ACCESSWIRE / January 27, 2020, / Else Nutrition Holdings Inc. (TSX.V:BABY) (OTCQB:BABYF) (“Else Nutrition“, “Else” or the “Company“), a developer of a real alternative to dairy-based infant nutrition, is pleased to announce ... [Read]
      Biotechnology

      Axovant Sciences Ltd. Shares Have Dropped Over 50% Today, Here’s Why.

      Jan 8 Chelsea Roh
      Switzerland-based Axovant Sciences Ltd (NASDAQ:AXON) shares have plummeted over 50% today as it announces it has scrapped its program and experiments for curing a type of dementia. The drug was called intrepirdine and it has ... [Read]
      Community Health Systems
      Health Services

      Community Health Systems will Participate in Citi 2017 Global Healthcare Conference

      Dec 1 Samara Malkin
      Community Health Systems, Inc. (NYSE:CYH) will be participating in the Citi 2017 Global Healthcare Conference, held on December 6-7, 2017 at The Lotte New York Palace Hotel in New York. The investor presentation will be ... [Read]
      Non-Brokered Private Placement
      Health

      3D Signatures Raising $1.5 Million Through Non-Brokered Private Placement

      Nov 29 Samara Malkin
      3D Signatures Inc. (TSXV:DXD) will be raising $1.5 million by a non-brokered private placement of 7.5 million units at $0.20 per unit. Each unit will consist of one common share of the company, as well ... [Read]
      Spectrum Pharmaceuticals Stock Soared
      Drugs

      This is Why Spectrum Pharmaceuticals Stock Soared in October

      Nov 8 Jen Jiang
      Spectrum Pharmaceuticals’ (NASDAQ:$SPPI) preliminary lung cancer data sparked a notable rally in its shares last month. Specifically, Spectrum, a small-cap oncology company, saw its shares gaining a  whopping 29.2% in October, according to S&P Global ... [Read]
      Community Health Systems Inc
      Health

      Before Investing in Community Health Systems Inc: Understand Beta

      Oct 24 Jen Jiang
      If you are interested in investing in Community Health Systems Inc. (NYSE:$CYH) or currently own the stock, then you must understand its beta in order to successfully minimize risks to your portfolio. Specifically, there are ... [Read]
      Impax Laboratories a Buy
      Drug Manufacturers

      Is Impax Laboratories a Buy At $16?

      Oct 20 Dylan Bernhardt
      Impax Laboratories (NASDAQ:$IPXL) currently has a going rate of $20.75 per share. This could be a shaky proposition for some investors. However, there may be another way to get in on the drug manufacturer’s stock. ... [Read]
      Application Software

      What are the Indicators Telling Us About Reliq Health Technologies, Inc.?

      Oct 20 Dylan Bernhardt
      Recently, Reliq Health Technologies, Inc. (TSXV:$RHT) has seen its SuperTrend line drop below the current stock price. This signal can alert investors that the stock has possibly entered the ‘Sell’ territory. So what are the ... [Read]

      Posts pagination

      1 2 »

      YOU MAY ALSO LIKE

      • Optimi Health
        Optimi Health Has Completed the Largest Legal Harvest of Natural Psilocybin in Canadian History.
        Sep 15 Chinedu Okoro
      • Cardinal Health Reveals Governance Enhancements And Shareholder Value Creation Programs
        Cardinal Health Reveals Governance Enhancements And Shareholder Value Creation Programs
        Sep 9 Adewumi Victor
      • HBO Max Eliminates Approximately 200 'Sesame Street' Episodes
        HBO Max Eliminates Approximately 200 ‘Sesame Street’ Episodes
        Aug 19 Peter Olaoluwapo
      • Blue Water Assumes Administration of Rising River RV Resort and River House
        Blue Water Assumes Administration of Rising River RV Resort and River House
        Aug 19 Peter Olaoluwapo
      • FDA Approves Bayer’s Nubeqa for Wider Use in Prostate Cancer Subtype.
        FDA Approves Bayer’s Nubeqa for Wider Use in Prostate Cancer Subtype.
        Aug 9 Peter Olaoluwapo
      Subscribe & Get The LATEST Stock Pick Alerts
      I want e-mail alerts, updates, and offers and agree to the MicroSmallCap privacy policy.
      Advertise With Us
      • Write for Us
      • Submit Press Release
      • Submit Sponsored Post
      Company
      • Authors
      • Contact Us
      Legal
      • Terms of Use
      • Privacy Policy
      • DMCA Policy
      • Disclaimer
      Follow Us

      Copyright © 2025 | #170 - 422 Richards Street Vancouver, BC, Canada V6B 2Z4 | 1.800.340.9767

      Copyright © 2025 | Terms of Use | Privacy Policy | DMCA | Disclaimer | Authors

      #170 - 422 Richards Street Vancouver, BC, Canada V6B 2Z4 | 1.800.340.9767